Chang David D (CIK 0001611024)

Latest company ownership

Shares held
2,913,196
Last filed at
May 20, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2018Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 14, 2025 Mar 18, 2025 Allogene Therapeutics, Inc. CEO Sell 45.0 -46,668 -0.57% ✗ $91.5K
Feb 3, 2025 Feb 5, 2025 Allogene Therapeutics, Inc. CEO Sell 45.0 -46,003 -0.56% ✗ $77.3K
Mar 14, 2024 Mar 18, 2024 Allogene Therapeutics, Inc. CEO Sell 45.0 -53,393 -0.72% ✗ $231.2K
Mar 14, 2023 Mar 16, 2023 Allogene Therapeutics, Inc. CEO Sell 47.5 -22,340 -0.43% ✗ $124.2K
Mar 15, 2022 Mar 17, 2022 Allogene Therapeutics, Inc. CEO Sell 47.5 -23,648 -0.45% ✗ $180.9K
Mar 15, 2021 Mar 17, 2021 Allogene Therapeutics, Inc. CEO Sell 45.0 -20,513 -0.43% ✗ $791.3K
Mar 16, 2020 Mar 18, 2020 Allogene Therapeutics, Inc. CEO Sell 45.0 -20,335 -0.36% ✗ $392.6K
Oct 15, 2018 Oct 17, 2018 Allogene Therapeutics, Inc. CEO Buy 85.0 +40,000 1.10% ✗ $720K